AI assistant
Sending…
Oxford Biomedica PLC — Major Shareholding Notification 2017
Apr 4, 2017
5190_rns_2017-04-04_41477d57-3b43-4fd0-aabc-4b979dbabc96.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4499B
Oxford Biomedica PLC
04 April 2017
TR-1: Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i | ||||||
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: | Oxford BioMedica plc | |||||
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) | ||||||
| Non-UK issuer | ||||||
| 2. Reason for the notification (please mark the appropriate box or boxes with an "X") | ||||||
| An acquisition or disposal of voting rights | X | |||||
| An acquisition or disposal of financial instruments | ||||||
| An event changing the breakdown of voting rights | ||||||
| Other (please specify)iii: | ||||||
| 3. Details of person subject to the notification obligationiv | ||||||
| Name | Joy Group Limited | |||||
| City and country of registered office (if applicable) | Road Town, Tortola, BVI | |||||
| 4. Full name of shareholder(s) (if different from 3.)v | ||||||
| Name | ||||||
| City and country of registered office (if applicable) | ||||||
| 5. Date on which the threshold was crossed or reachedvi: | Trade date 03/04/2017 / Value date 05/04/2017 | |||||
| 6. Date on which issuer notified (DD/MM/YYYY): | 04/04/2017 | |||||
| 7. Total positions of person(s) subject to the notification obligation | ||||||
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) | Total number of voting rights of issuervii | |||
| Resulting situation on the date on which threshold was crossed or reached | 6.9% | |||||
| Position of previous notification (if applicable) |
N/A | |||||
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii | |||||||||
| A: Voting rights attached to shares | |||||||||
| Class/type of shares ISIN code (if possible) |
Number of voting rightsix | % of voting rights | |||||||
| Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
||||||
| GB0006648157 | 215,793,548 | 6.9% | |||||||
| SUBTOTAL 8. A | 215,793,548 | 6.9% | |||||||
| B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) | |||||||||
| Type of financial instrument | Expiration datex |
Exercise/ Conversion Periodxi |
Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights | |||||
| N/A | |||||||||
| SUBTOTAL 8. B 1 | |||||||||
| B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) | |||||||||
| Type of financial instrument | Expiration datex |
Exercise/ Conversion Period xi |
Physical or cash settlementxii |
Number of voting rights | % of voting rights | ||||
| N/A | |||||||||
| SUBTOTAL 8.B.2 | |||||||||
| 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") |
||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii | ||||
| Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary) |
X | |||
| Namexv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | |
| Joy Group Limited | 6.9% | |||
| Proxy voting | ||||
| 10. Name of the proxy holder | See section 3 | |||
| 11. The number and % of voting rights held | ||||
| 12. The date until which the voting rights will be held | ||||
| 13. Additional informationxvi | ||||
| Joy Group Limited is a controlled undertaking of The Al Joy 1 Trust, which is a trust registered in Jersey | ||||
| 14. Contact name: | Tim Watts |
| 15. Contact telephone number: | 01865 783000 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUOARRBRASRUR
More from Oxford Biomedica PLC
Regulatory Filings
2026
May 7
AGM Information
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 1
Regulatory Filings
2026
Apr 30
Share Issue/Capital Change
2026
Apr 27
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Apr 8
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 1
Annual Report
2026
Mar 30
Annual Report (ESEF)
2026
Mar 30